US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
US3971852A
(en)
|
1973-06-12 |
1976-07-27 |
Polak's Frutal Works, Inc. |
Process of encapsulating an oil and product produced thereby
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
IT1090703B
(it)
|
1976-12-03 |
1985-06-26 |
Scherer Ltd R P |
Perfezionamento nelle composizioni utili quali veicolo per farmaci
|
US4123403A
(en)
|
1977-06-27 |
1978-10-31 |
The Dow Chemical Company |
Continuous process for preparing aqueous polymer microsuspensions
|
US4279632A
(en)
|
1979-05-08 |
1981-07-21 |
Nasa |
Method and apparatus for producing concentric hollow spheres
|
IT1148784B
(it)
|
1980-04-09 |
1986-12-03 |
Eurand Spa |
Procedimento per la preparazione di microcapsule in un veicolo liquido
|
US4379454A
(en)
|
1981-02-17 |
1983-04-12 |
Alza Corporation |
Dosage for coadministering drug and percutaneous absorption enhancer
|
JPS5877810A
(ja)
|
1981-11-01 |
1983-05-11 |
Taiho Yakuhin Kogyo Kk |
ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物
|
DE3224619A1
(de)
|
1981-07-14 |
1983-05-19 |
Freund Industrial Co., Ltd., Tokyo |
Orale pharmazeutische zusammensetzung
|
JPS5813508A
(ja)
|
1981-07-14 |
1983-01-26 |
Taiho Yakuhin Kogyo Kk |
ポリグリセロール飽和脂肪酸エステルを含む経口薬剤組成物
|
US4481157A
(en)
|
1982-04-27 |
1984-11-06 |
Morishita Jintan Co., Ltd. |
Method and apparatus for production of microcapsules
|
US4597959A
(en)
|
1982-04-30 |
1986-07-01 |
Arthur Barr |
Sustained release breath freshener, mouth and palate coolant wafer composition and method of use
|
US4422985A
(en)
|
1982-09-24 |
1983-12-27 |
Morishita Jintan Co., Ltd. |
Method and apparatus for encapsulation of a liquid or meltable solid material
|
JPS5988420A
(ja)
|
1982-11-12 |
1984-05-22 |
Teisan Seiyaku Kk |
シ−ムレスカプセル化ニフエジピン製剤
|
US4502888A
(en)
|
1982-12-13 |
1985-03-05 |
The Dow Chemical Company |
Aqueous dispersions of plasticized polymer particles
|
JPS59131355A
(ja)
|
1983-01-17 |
1984-07-28 |
森下仁丹株式会社 |
多重軟カプセルの製法
|
HU187215B
(en)
|
1983-01-26 |
1985-11-28 |
Egyt Gyogyszervegyeszeti Gyar |
Method for producing pharmaceutical product of high actor content and prolonged effect
|
US4772466A
(en)
*
|
1983-08-22 |
1988-09-20 |
Syntex (U.S.A.) Inc. |
Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
|
DE3331009A1
(de)
|
1983-08-27 |
1985-03-14 |
Basf Ag, 6700 Ludwigshafen |
Verfahren zur erhoehung der enteralen resorbierbarkeit von heparin bzw. heparinoiden sowie das so erhaeltliche heparin- bzw. heparinoidpraeparat
|
JPS60100516A
(ja)
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
US4659700A
(en)
|
1984-03-02 |
1987-04-21 |
Johnson & Johnson Products, Inc. |
Chitosan-glycerol-water gel
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
JPS61126016A
(ja)
*
|
1984-11-22 |
1986-06-13 |
Toagosei Chem Ind Co Ltd |
不飽和脂肪酸を内相物としたマイクロカプセル
|
JPS61151119A
(ja)
|
1984-12-24 |
1986-07-09 |
Taisho Pharmaceut Co Ltd |
ソフトカプセル
|
US4601894A
(en)
|
1985-03-29 |
1986-07-22 |
Schering Corporation |
Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
|
US4749574A
(en)
|
1986-04-14 |
1988-06-07 |
Fujisawa Pharmaceutical Co., Ltd. |
Sustained-release transdermal delivery preparations
|
US6024983A
(en)
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
US4857335A
(en)
|
1987-03-27 |
1989-08-15 |
Lim Technology Laboratories, Inc. |
Liquid controlled release formulations and method of producing same via multiple emulsion process
|
DE3851152T2
(de)
|
1987-09-03 |
1995-01-26 |
Univ Georgia |
Cyclosporin-augenmittel.
|
US5376369A
(en)
*
|
1987-11-03 |
1994-12-27 |
Syntex (U.S.A.) Inc. |
Vaccine adjuvant
|
JPS6415A
(en)
|
1988-03-17 |
1989-01-05 |
Freunt Ind Co Ltd |
Absorption-improving drug preparation
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
US5342625A
(en)
|
1988-09-16 |
1994-08-30 |
Sandoz Ltd. |
Pharmaceutical compositions comprising cyclosporins
|
GB2222770B
(en)
|
1988-09-16 |
1992-07-29 |
Sandoz Ltd |
Pharmaceutical compositions containing cyclosporins
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
JP2806564B2
(ja)
|
1989-07-20 |
1998-09-30 |
森下仁丹株式会社 |
親水性物質を内容物とするシームレスカプセルおよびその製法
|
GB2237510B
(en)
*
|
1989-11-04 |
1993-09-15 |
Danbiosyst Uk |
Small particle drug compositions for nasal administration
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
US5260071A
(en)
|
1989-12-18 |
1993-11-09 |
Lemelson Jerome H |
Drug units and methods for using same
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
DK0465238T3
(da)
|
1990-07-04 |
1994-05-02 |
Shionogi & Co |
Fremgangsmåde til fremstilling af ikke-kohæsive overtræk
|
US5418010A
(en)
|
1990-10-05 |
1995-05-23 |
Griffith Laboratories Worldwide, Inc. |
Microencapsulation process
|
US5102668A
(en)
|
1990-10-05 |
1992-04-07 |
Kingaform Technology, Inc. |
Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
GB9113872D0
(en)
|
1991-06-27 |
1991-08-14 |
Sandoz Ag |
Improvements in or relating to organic compounds
|
AU661021B2
(en)
|
1991-06-28 |
1995-07-13 |
Brown University Research Foundation |
Capsule extrusion systems
|
JP3313124B2
(ja)
|
1991-07-31 |
2002-08-12 |
森下仁丹株式会社 |
親水性物質を内容物とするシームレスカプセルおよびその製法
|
JPH0549899A
(ja)
|
1991-08-09 |
1993-03-02 |
Japan Tobacco Inc |
ビーズ及びこれを製造するための液滴生成装置
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
AU666895B2
(en)
*
|
1991-12-30 |
1996-02-29 |
Hercules Incorporated |
High load spray dry encapsulation
|
DE4201179A1
(de)
|
1992-01-17 |
1993-07-22 |
Alfatec Pharma Gmbh |
Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
|
ES2108258T3
(es)
|
1992-01-17 |
1997-12-16 |
Alfatec Pharma Gmbh |
Granulos que contienen sustancias medicamentosas peptidicas y su preparacion asi como su empleo.
|
US5571533A
(en)
|
1992-02-07 |
1996-11-05 |
Recordati, S.A., Chemical And Pharmaceutical Company |
Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
|
US6235320B1
(en)
*
|
1992-05-11 |
2001-05-22 |
General Mills, Inc. |
Colored multi-layered yogurt and methods of preparation
|
DE69324523T2
(de)
|
1992-06-12 |
1999-09-09 |
Kao Corp. |
Badezusatzzusammensetzung enthaltend oberflächenaktive Mittel enthaltende nahtlose Kapsel und Verfahren zur Herrstellung der Kapsel
|
US5352448A
(en)
|
1992-07-20 |
1994-10-04 |
Purdue Research Foundatioin |
Oral administration of antigens
|
JP3405746B2
(ja)
|
1992-10-28 |
2003-05-12 |
フロイント産業株式会社 |
シームレスカプセルの製造方法
|
EP0678035B9
(de)
*
|
1993-01-08 |
2006-12-13 |
Csl Limited |
Impfstoffpräparate
|
GB9300875D0
(en)
|
1993-01-18 |
1993-03-10 |
Ucb Sa |
Nanocapsule containing pharmaceutical compositions
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
US5914132A
(en)
|
1993-02-26 |
1999-06-22 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
US5686105A
(en)
|
1993-10-19 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
JPH06254382A
(ja)
*
|
1993-03-05 |
1994-09-13 |
Riken Vitamin Co Ltd |
マイクロカプセルの製造法およびその製造装置
|
US5843347A
(en)
|
1993-03-23 |
1998-12-01 |
Laboratoire L. Lafon |
Extrusion and freeze-drying method for preparing particles containing an active ingredient
|
CN1077800C
(zh)
|
1993-07-01 |
2002-01-16 |
韩美药品工业株式会社 |
环孢菌素软胶囊组合物
|
FR2707184B1
(fr)
|
1993-07-08 |
1995-08-11 |
Rhone Poulenc Nutrition Animal |
Procédé de préparation de sphérules contenant un principe actif alimentaire ou pharmaceutique.
|
US5562909A
(en)
|
1993-07-12 |
1996-10-08 |
Massachusetts Institute Of Technology |
Phosphazene polyelectrolytes as immunoadjuvants
|
DE4329503A1
(de)
|
1993-09-01 |
1995-03-02 |
Galenik Labor Freiburg Gmbh |
Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
|
DE4332041C2
(de)
|
1993-09-21 |
1997-12-11 |
Rentschler Arzneimittel |
Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
|
US5500161A
(en)
|
1993-09-21 |
1996-03-19 |
Massachusetts Institute Of Technology And Virus Research Institute |
Method for making hydrophobic polymeric microparticles
|
US5961970A
(en)
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
US5498439A
(en)
|
1994-03-04 |
1996-03-12 |
Arnhem, Inc. |
Process for encapsulating the flavor with colloid gel matrix
|
GB9405304D0
(en)
|
1994-03-16 |
1994-04-27 |
Scherer Ltd R P |
Delivery systems for hydrophobic drugs
|
FR2721510B1
(fr)
|
1994-06-22 |
1996-07-26 |
Rhone Poulenc Rorer Sa |
Nanoparticules filtrables dans des conditions stériles.
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
US5650232A
(en)
|
1994-10-07 |
1997-07-22 |
Warner-Lambert Company |
Method for making seamless capsules
|
FR2725623A1
(fr)
|
1994-10-18 |
1996-04-19 |
Flamel Tech Sa |
Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
|
US5827531A
(en)
|
1994-12-02 |
1998-10-27 |
The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration |
Microcapsules and methods for making
|
US5529783A
(en)
|
1994-12-19 |
1996-06-25 |
Mcneil-Ppc, Inc. |
Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
|
KR0167613B1
(ko)
|
1994-12-28 |
1999-01-15 |
한스 루돌프 하우스, 니콜 케르커 |
사이클로스포린-함유 연질캅셀제 조성물
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
US5674495A
(en)
|
1995-02-27 |
1997-10-07 |
Purdue Research Foundation |
Alginate-based vaccine compositions
|
US5595757A
(en)
|
1995-03-29 |
1997-01-21 |
Warner-Lambert Company |
Seamless capsules
|
US5665386A
(en)
|
1995-06-07 |
1997-09-09 |
Avmax, Inc. |
Use of essential oils to increase bioavailability of oral pharmaceutical compounds
|
US5716928A
(en)
|
1995-06-07 |
1998-02-10 |
Avmax, Inc. |
Use of essential oils to increase bioavailability of oral pharmaceutical compounds
|
IE80467B1
(en)
|
1995-07-03 |
1998-07-29 |
Elan Corp Plc |
Controlled release formulations for poorly soluble drugs
|
SE504582C2
(sv)
|
1995-07-06 |
1997-03-10 |
Gs Dev Ab |
Cyklosporinkomposition baserad på en L2-fas
|
MX9702809A
(es)
|
1995-08-25 |
1998-02-28 |
Sangstat Medical Corp |
Formulaciones orales de ciclosporina.
|
EP0760237A1
(de)
|
1995-08-30 |
1997-03-05 |
Cipla Limited |
Öl-in-Wasser-Mikroemulsionen
|
DE19549852B4
(de)
|
1995-11-29 |
2009-06-04 |
Novartis Ag |
Cyclosporin enthaltende Präparate
|
JP3759986B2
(ja)
|
1995-12-07 |
2006-03-29 |
フロイント産業株式会社 |
シームレスカプセルおよびその製造方法
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
US5686133A
(en)
|
1996-01-31 |
1997-11-11 |
Port Systems, L.L.C. |
Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
|
US6015576A
(en)
|
1997-08-29 |
2000-01-18 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to an antigen
|
KR0183449B1
(ko)
|
1996-06-19 |
1999-05-01 |
한스 루돌프 하우스, 니콜 케르커 |
사이클로스포린-함유 연질캅셀제
|
US5958876A
(en)
|
1996-06-19 |
1999-09-28 |
Novartis Ag |
Cyclosporin-containing pharmaceutical compositions
|
ATE277739T1
(de)
|
1996-10-28 |
2004-10-15 |
Gen Mills Inc |
Einbettung und einkapselung von teilchen zur kontrollierten abgabe
|
US5891474A
(en)
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
DZ2479A1
(fr)
|
1997-05-05 |
2003-02-01 |
Pfizer |
Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.
|
WO1998050018A1
(en)
|
1997-05-06 |
1998-11-12 |
Xiao Yu Wu |
Drug delivery system
|
JP4102459B2
(ja)
|
1997-05-14 |
2008-06-18 |
森下仁丹株式会社 |
生体高分子を合成するシームレスカプセルおよびその製造方法
|
SE9702533D0
(sv)
|
1997-07-01 |
1997-07-01 |
Astra Ab |
New oral formulation
|
SI0999826T1
(en)
|
1997-07-29 |
2004-12-31 |
Pharmacia & Upjohn Company |
Self-emulsifying formulation for lipophilic compounds
|
ES2137862B1
(es)
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
JP3090198B2
(ja)
|
1997-08-21 |
2000-09-18 |
日本電気株式会社 |
半導体装置の構造およびその製造方法
|
EP1009382B1
(de)
*
|
1997-09-05 |
2003-06-18 |
GlaxoSmithKline Biologicals S.A. |
Öl in wasser emulsionen mit saponinen
|
HUP9701554D0
(en)
|
1997-09-18 |
1997-11-28 |
Human Oltoanyagtermeloe Gyogys |
Pharmaceutical composition containing plazma proteins
|
TW575420B
(en)
|
1997-09-22 |
2004-02-11 |
Kirin Brewery |
Composition for enhancing cellular immunogenicity comprising alpha-glycosylceramides
|
KR100569319B1
(ko)
|
1997-10-30 |
2006-04-07 |
모리시타 진탄 가부시키가이샤 |
불포화 지방산 또는 이들의 유도체를 내용물로 하는 캡슐제제 및 그의 제조방법
|
IT1296585B1
(it)
|
1997-11-28 |
1999-07-14 |
Uni Di Pavia |
Microcapsule contenenti materiale seminale per l'inseminazione strumentale nella specie suina
|
US6509346B2
(en)
|
1998-01-21 |
2003-01-21 |
Millennium Pharmaceuticals, Inc. |
Chemokine receptor antagonists and methods of use therefor
|
US20040062802A1
(en)
|
1998-04-02 |
2004-04-01 |
Hermelin Victor M. |
Maximizing effectiveness of substances used to improve health and well being
|
AU3344299A
(en)
*
|
1998-04-20 |
1999-11-08 |
Shionogi & Co., Ltd. |
Th2-migration promoters containing w/o emulsions
|
US6174466B1
(en)
|
1998-05-08 |
2001-01-16 |
Warner-Lambert Company |
Methods for making seamless capsules
|
JPH11322587A
(ja)
|
1998-05-18 |
1999-11-24 |
Sumitomo Chem Co Ltd |
常温で固体の生理活性物質のマイクロカプセル化方法およびこの方法により得られるマイクロカプセル組成物
|
KR100336090B1
(ko)
|
1998-06-27 |
2002-05-27 |
윤승원 |
오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
|
GB9818591D0
(en)
|
1998-08-27 |
1998-10-21 |
Danbiosyst Uk |
Pharmaceutical composition
|
DE19848849A1
(de)
|
1998-10-22 |
2000-04-27 |
Knoll Ag |
Verfahren zur Herstellung von festen, sphärischen Formen, enthaltend eine biologisch aktive Substanz
|
AU775523B2
(en)
|
1998-12-11 |
2004-08-05 |
Pharmasolutions, Inc. |
Self-emulsifying compositions for drugs poorly soluble in water
|
JP3039863B1
(ja)
|
1998-12-25 |
2000-05-08 |
不二精工株式会社 |
ロッキングプレス装置
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
US20030104048A1
(en)
|
1999-02-26 |
2003-06-05 |
Lipocine, Inc. |
Pharmaceutical dosage forms for highly hydrophilic materials
|
JP2000247911A
(ja)
|
1999-02-26 |
2000-09-12 |
Hisamitsu Pharmaceut Co Inc |
大腸用吸収促進剤
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
JP2000302654A
(ja)
|
1999-04-16 |
2000-10-31 |
Kao Corp |
歯磨組成物の製造法
|
AU4428000A
(en)
|
1999-05-14 |
2000-12-05 |
Coraltis Ltd. |
Pulse-delivery oral compositions
|
WO2000074720A1
(fr)
|
1999-06-09 |
2000-12-14 |
Mochida Pharmaceutical Co., Ltd. |
Systeme de liberation dans les voies digestives inferieures
|
US20030236236A1
(en)
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
US20030235595A1
(en)
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
NZ516733A
(en)
|
1999-07-30 |
2004-03-26 |
Smithkline Beecham Plc |
Pharmaceutical formulations for oral dosing that are dosage forms comprising two or more connected sub-units
|
DE69937580D1
(de)
*
|
1999-08-18 |
2007-12-27 |
Ind Academic Coop |
Agent zur induktion einer immunologischen toleranz
|
AU1043201A
(en)
|
1999-11-02 |
2001-05-14 |
Cipla Limited |
Cyclosporin formulation
|
US20030180352A1
(en)
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20060034937A1
(en)
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20010026800A1
(en)
|
2000-01-07 |
2001-10-04 |
Michael Jacob G. |
Selective activation of a TH1 or TH2 lymphocyte regulated immune response
|
EP1280521B1
(de)
|
2000-05-12 |
2005-07-20 |
Pharmacia & Upjohn Company LLC |
Impfstoffzusammensetzung und verfahren zur herstellung derselben sowie verfahren zur impfung von wirbeltieren
|
US20040258702A1
(en)
|
2000-06-22 |
2004-12-23 |
Blonder Joan P. |
Vaccine delivery
|
GB0018527D0
(en)
|
2000-07-27 |
2000-09-13 |
Photocure Asa |
Composition
|
US6565888B1
(en)
*
|
2000-08-23 |
2003-05-20 |
Alkermes Controlled Therapeutics, Inc. |
Methods and compositions for the targeted delivery of biologically active agents
|
FI20002215A0
(fi)
|
2000-10-06 |
2000-10-06 |
Orion Yhtymae Oyj |
Yhdistelmäpartikkelit
|
AU2002250071B2
(en)
|
2001-02-13 |
2008-02-14 |
Government Of The United States, As Represented By The Secretary Of The Army |
Vaccine for transcutaneous immunization
|
EP1434859A2
(de)
*
|
2001-07-25 |
2004-07-07 |
New York University |
Verwendung von glycosylceramiden als adjuvantien für vakzine gegen infektionen und krebs
|
US6585997B2
(en)
|
2001-08-16 |
2003-07-01 |
Access Pharmaceuticals, Inc. |
Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
|
US20030083286A1
(en)
|
2001-08-22 |
2003-05-01 |
Ching-Leou Teng |
Bioadhesive compositions and methods for enhanced intestinal drug absorption
|
US6669955B2
(en)
|
2001-08-28 |
2003-12-30 |
Longwood Pharmaceutical Research, Inc. |
Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
|
FR2830447B1
(fr)
|
2001-10-09 |
2004-04-16 |
Flamel Tech Sa |
Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
|
US6951655B2
(en)
|
2001-10-11 |
2005-10-04 |
Imi Biomed, Inc. |
Pro-micelle pharmaceutical compositions
|
US20040126428A1
(en)
|
2001-11-02 |
2004-07-01 |
Lyn Hughes |
Pharmaceutical formulation including a resinate and an aversive agent
|
CA2471241A1
(en)
|
2001-12-20 |
2003-07-03 |
Bernard Charles Sherman |
Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
|
MXPA04006674A
(es)
|
2002-01-10 |
2004-10-04 |
Firmenich & Cie |
Proceso para la preparacion de sistemas de suministro extruidos.
|
US6949256B2
(en)
|
2002-01-18 |
2005-09-27 |
Banner Pharmacaps, Inc. |
Non-gelatin capsule shell formulation
|
JP4429590B2
(ja)
*
|
2002-02-08 |
2010-03-10 |
株式会社協和ウェルネス |
ユビキノン含有水可溶性組成物
|
US6974592B2
(en)
|
2002-04-11 |
2005-12-13 |
Ocean Nutrition Canada Limited |
Encapsulated agglomeration of microcapsules and method for the preparation thereof
|
US20030207907A1
(en)
|
2002-05-03 |
2003-11-06 |
Iversen Patrick L. |
Delivery of microparticle-conjugated drugs for inhibition of stenosis
|
JP4226846B2
(ja)
|
2002-06-07 |
2009-02-18 |
キャタレント・ジャパン株式会社 |
口腔内で崩壊可能なソフトカプセル剤
|
JP2004043332A
(ja)
*
|
2002-07-09 |
2004-02-12 |
Nof Corp |
経口用リポソーム製剤
|
CA2499423A1
(en)
|
2002-09-04 |
2004-03-18 |
Niraj Vasisht |
Microencapsulation of oxygen or water sensitive materials
|
US7521431B2
(en)
|
2002-11-01 |
2009-04-21 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for siRNA inhibition of HIF-1 alpha
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
US7524515B2
(en)
|
2003-01-10 |
2009-04-28 |
Mutual Pharmaceuticals, Inc. |
Pharmaceutical safety dosage forms
|
WO2004064997A1
(en)
|
2003-01-23 |
2004-08-05 |
Inotech Ag |
New microcapsules useful as extraction means in particular for extracting water or soil contaminants
|
US20060167435A1
(en)
|
2003-02-18 |
2006-07-27 |
Adamis Anthony P |
Transscleral drug delivery device and related methods
|
JP2006521366A
(ja)
*
|
2003-03-28 |
2006-09-21 |
シグモイド・バイオテクノロジーズ・リミテッド |
シームレスマイクロカプセルを含む固形経口剤形
|
DK1613346T3
(da)
*
|
2003-04-04 |
2013-01-07 |
Pah Usa 15 Llc |
Mikrofluidiske olie-i-vand-emulsioner og vaccinesammensætninger
|
DE602004028023D1
(de)
|
2003-08-29 |
2010-08-19 |
Lifecycle Pharma As |
Tacrolimus enthaltende feste dispersionen
|
US7087237B2
(en)
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
JP2005119986A
(ja)
*
|
2003-10-15 |
2005-05-12 |
Japan Science & Technology Agency |
生理活性物質の投与方法、生理活性物質含有乳化液、及び生理活性物質含有乳化液の製造方法
|
US20050095288A1
(en)
|
2003-11-03 |
2005-05-05 |
Andrx Labs, Llc |
Decongestant and expectorant tablets
|
ES2373937T3
(es)
|
2003-11-21 |
2012-02-10 |
Commonwealth Scientific And Industrial Research Organisation |
Sistemas gastro-intestinales de administración.
|
EP1697511A4
(de)
|
2003-12-11 |
2007-11-21 |
Vaxdesign Corp |
Immuntherapiezusammensetzungen, verfahren zur herstellung und verfahren zur verwendung davon
|
CN1268325C
(zh)
*
|
2004-01-18 |
2006-08-09 |
浙江大学 |
三重复合微球制剂及其制备方法
|
JP2007519756A
(ja)
|
2004-01-30 |
2007-07-19 |
アンジオテック インターナショナル アーゲー |
拘縮を治療するための組成物および方法
|
TW201240679A
(en)
|
2004-03-12 |
2012-10-16 |
Capsugel Belgium Nv |
Pharmaceutical formulations
|
FR2867395B1
(fr)
*
|
2004-03-15 |
2006-06-16 |
Rhodia Chimie Sa |
Emulsion sechee, son procede de preparation, et ses utilisations
|
EP1742659B1
(de)
*
|
2004-04-05 |
2013-03-13 |
Pah Usa 15 Llc |
Mikrofluidisierte öl-in-wasser-emulsionen und vakzinezusammensetzungen
|
GB0417481D0
(en)
|
2004-08-05 |
2004-09-08 |
Etiologics Ltd |
Combination therapy
|
US20070248683A1
(en)
*
|
2004-08-19 |
2007-10-25 |
Elger Funda |
Novel Compositions of Fat-Soluble Substances
|
WO2006026592A2
(en)
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Oral administration of poorly absorbed drugs, methods and compositions related thereto
|
EP1789090A2
(de)
|
2004-09-02 |
2007-05-30 |
Bionaut Pharmaceuticals, Inc. |
Kombinatorische chemotherapiebehandlung mit na+/k+-atpase-hemmern
|
GB0419846D0
(en)
*
|
2004-09-07 |
2004-10-13 |
Chiron Srl |
Vaccine adjuvants for saccharides
|
CA2581816A1
(en)
|
2004-09-27 |
2006-04-06 |
Sigmoid Biotechnologies Limited |
Microcapsules comprising a methylxanthine and a corticosteroid
|
GB0506001D0
(en)
*
|
2005-03-23 |
2005-04-27 |
Glaxosmithkline Biolog Sa |
Novel use
|
US20090081253A1
(en)
*
|
2005-03-23 |
2009-03-26 |
Glaxosmithkline Biologicals S.A. |
Composition
|
EP1868567A4
(de)
|
2005-03-29 |
2010-09-29 |
Mcneil Ppc Inc |
Zusammensetzungen mit hydrophilen arzneimitteln in einem hydrophoben medium
|
JP2008535921A
(ja)
|
2005-04-12 |
2008-09-04 |
エラン・ファルマ・インターナショナル・リミテッド |
シクロスポリンを含むナノ粒子および放出調節された組成物
|
KR100764678B1
(ko)
*
|
2005-07-13 |
2007-10-09 |
재단법인서울대학교산학협력재단 |
알파-갈락토실세라마이드를 아쥬반트로 포함하는 비강투여용 백신 조성물
|
TW200800305A
(en)
|
2005-07-26 |
2008-01-01 |
Glaxo Group Ltd |
Encapsulation of lipid-based formulations in enteric polymers
|
EP1909771A1
(de)
|
2005-08-02 |
2008-04-16 |
Miv Therapeutics Inc. |
Mikrovorrichtungen mit nanokapseln für die kontrollierte abgabe von arzneimitteln und herstellungsverfahren dafür
|
US20080032028A1
(en)
*
|
2006-08-15 |
2008-02-07 |
Gohil Rameshchandra M |
Succulent snacks
|
US8039010B2
(en)
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
US20080124279A1
(en)
|
2006-11-17 |
2008-05-29 |
Antoine Andremont |
Colonic delivery using Zn/pectin beads with a Eudragit coating
|
CA2683409A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Sigmoid Pharma Limited |
A pharmaceutical composition of tacrolimus
|
MY180465A
(en)
|
2007-04-06 |
2020-11-30 |
Takeda Vaccines Inc |
Methods and compositions for live attenuated viruses
|
ES2963291T3
(es)
|
2007-04-26 |
2024-03-26 |
Sublimity Therapeutics Ltd |
Fabricación de múltiples minicápsulas
|
US20100239665A1
(en)
|
2007-05-01 |
2010-09-23 |
Ivan Coulter |
Pharmaceutical nimodipine compositions
|
US9833510B2
(en)
|
2007-06-12 |
2017-12-05 |
Johnson & Johnson Consumer Inc. |
Modified release solid or semi-solid dosage forms
|
ES2574825T3
(es)
*
|
2007-10-12 |
2016-06-22 |
Luigi Panza |
Análogos de glicolípidos útiles como inmunoadyuvantes
|
CA2659917C
(en)
|
2008-03-24 |
2012-07-17 |
Advanced Bionutrition Corp. |
Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
|
WO2009156960A2
(en)
*
|
2008-06-27 |
2009-12-30 |
Pfizer Inc. |
Novel adjuvant compositions
|
EP2432455B1
(de)
*
|
2009-05-18 |
2014-11-12 |
Sigmoid Pharma Limited |
Zusammensetzung mit öltropfen
|
US20120213854A1
(en)
|
2010-09-30 |
2012-08-23 |
Fetzer Oliver S |
Methods of treating a subject and related particles, polymers and compositions
|